                         SEQUENCE LISTING

<110>  Isis Pharmaceuticals, Inc.
 
<120>  COMPOUNDS AND METHODS FOR DETECTING OLIGONUCLEOTIDES

<130>  CORE0121WO

<150>  61/902,112
<151>  2013-11-08

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
tcactttcat aatgctgg                                                     18


<210>  2
<211>  9
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
ccagcatta                                                                9


<210>  3
<211>  9
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
tgaaagtga                                                                9


<210>  4
<211>  14
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
tcagtcatga cttc                                                         14


<210>  5
<211>  7
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
gaagtca                                                                  7


<210>  6
<211>  7
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
tgactga                                                                  7


<210>  7
<211>  17
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  7
ggttcccgag gtgccca                                                      17


<210>  8
<211>  8
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  n = inosine

<400>  8
tgngcacc                                                                 8


